B
Bernd Wullich
Researcher at University of Erlangen-Nuremberg
Publications - 120
Citations - 3016
Bernd Wullich is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Bladder cancer & Prostate cancer. The author has an hindex of 27, co-authored 120 publications receiving 2308 citations. Previous affiliations of Bernd Wullich include Saarland University.
Papers
More filters
Journal ArticleDOI
Toward the blood-borne miRNome of human diseases
Andreas Keller,Petra Leidinger,Andrea S. Bauer,Abdou ElSharawy,Jan Haas,Christina Backes,Anke Wendschlag,Nathalia Giese,Christine Tjaden,Katja Ott,Jens Werner,Thilo Hackert,Klemens Ruprecht,Hanno Huwer,Junko Huebers,Gunnar Jacobs,Philip Rosenstiel,Henrik Dommisch,Arne S. Schaefer,Joachim Müller-Quernheim,Bernd Wullich,Bastian Keck,Norbert Graf,Joerg Reichrath,Britta Vogel,Almut Nebel,Sven Uwe Jager,Peer F Staehler,Ioannis Amarantos,Valesca Boisguerin,Cord F Staehler,Markus Beier,Matthias Scheffler,Markus W. Büchler,J Wischhusen,Sebastian F M Haeusler,Johannes Dietl,Sylvia Hofmann,Hans-Peter Lenhof,Stefan Schreiber,Hugo A. Katus,Wolfgang Rottbauer,Benjamin Meder,Joerg Hoheisel,Andre Franke,Eckart Meese +45 more
TL;DR: In a multicenter study, the expression profiles of 863 microRNAs were determined by array analysis of 454 blood samples from human individuals with different cancers or noncancer diseases, and this 'miRNome' was validated by quantitative real-time PCR.
Journal ArticleDOI
MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
Sven Wach,Elke Nolte,Jaroslaw Szczyrba,Robert Stöhr,Arndt Hartmann,Torben F. Ørntoft,Lars Dyrskjøt,Elke Eltze,Wolf F. Wieland,Bastian Keck,Arif B. Ekici,Friedrich A. Grässer,Bernd Wullich +12 more
TL;DR: The results indicate that combinations of miRNAs are promising biomarkers for the diagnosis of prostate cancer and extend the knowledge about the deregulation of mi RNAs in prostate cancer.
Journal ArticleDOI
Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.
Aline Flockerzi,Alessia Ruggieri,Oliver Frank,Marlies Sauter,Esther Maldener,Bernd Kopper,Bernd Wullich,Bernd Wullich,Wolfgang Seifarth,Nikolaus Müller-Lantzsch,Christine Leib-Mösch,Eckart Meese,Jens Mayer +12 more
TL;DR: The largest-scale study reveals in greater detail expression patterns of individual HML-2 loci in human tissues of clinical interest and underscores the need for large-scale, specialized studies to better comprehend transcriptional activity and regulation of HERVs.
Journal ArticleDOI
The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
Bastian Keck,Robert Stoehr,Sven Wach,Anja Rogler,Ferdinand Hofstaedter,Jan Lehmann,Rodolfo Montironi,Mathilde Sibonye,H.-M. Fritsche,Antonio Lopez-Beltran,Jonathan I. Epstein,Bernd Wullich,Arndt Hartmann +12 more
TL;DR: PUC is an aggressive variant of bladder cancer with molecular features of advanced bladder cancer and evidence of WNT pathway activation in some of the cases.
Journal ArticleDOI
68 Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.
Christian Schmidkonz,Michael Cordes,Daniela Schmidt,Tobias Bäuerle,Theresa Ida Goetz,Michael Beck,Olaf Prante,Alexander Cavallaro,Michael Uder,Bernd Wullich,Peter J. Goebell,Torsten Kuwert,Philipp Ritt +12 more
TL;DR: 68Ga-PSMA-11 PET/CT-derived metabolic tumor parameters showed promising results for evaluation of treatment response and especially, TL-PSma demonstrated higher agreement rates with biochemical response compared to SUVmax.